National Holdings Corporation Responds to Letter from CB Pharma Acquisition Corp.

NEW YORK--()--National Holdings Corporation (NASDAQ:NHLD) ("National Holdings" or the "Company"), a full-service investment banking and asset management firm, announced today that its Board of Directors has received a letter from CB Pharma Acquisition Corp. regarding a non-binding proposal to acquire National Holdings.

“Our Board of Directors acknowledges receipt of this letter will take up consideration of this non-binding letter in due course," stated Robert Fagenson, National Holdings’ Executive Chairman and Chief Executive Officer.

About National Holdings Corporation

National Holdings Corporation is a full-service investment banking and asset management firm that provides a range of services, including independent retail brokerage and advisory services, investment banking, institutional sales and trading and equity research, financial planning, market making, tax preparation, insurance and annuities, to corporations, institutional investors and high net-worth clients. With over 1,100 independent advisors, brokers, traders and sales associates, the Company is a leading Independent Advisor and Broker services company. National Holdings operates through five subsidiaries: National Securities Corporation, vFinance Investments, Inc., National Insurance Corporation, National Asset Management, Inc. and Gilman Ciocia, Inc. The Company was founded in 1947 and is headquartered in New York and Florida. For more information, visit www.nhldcorp.com.

Contacts

National Holdings Corporation
Robert Fagenson, +1 212-417-8210
Executive Chairman & Chief Executive Officer
or
LHA
Ed McGregor/Jody Burfening, +1 212-838-3777
emcgregor@lhai.com

Contacts

National Holdings Corporation
Robert Fagenson, +1 212-417-8210
Executive Chairman & Chief Executive Officer
or
LHA
Ed McGregor/Jody Burfening, +1 212-838-3777
emcgregor@lhai.com